Yichuan Yuan

发表

Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis

P. Ding, Yu-hong Li, Z. Pan, 2020, World Journal of Surgical Oncology.

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition

Yun-fei Yuan, Jiliang Qiu, Yuanping Zhang, 2021, FEBS open bio.

Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling

Y. Niu, Yun-fei Yuan, Chao-Zheng Zhang, 2022, Oncogene.

Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study

Jingxian Shen, Yun-fei Yuan, Wenwu Liu, 2019, Journal of Cancer.

Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study

Yun-fei Yuan, Ruhai Zou, Chen-Wei Wang, 2020, Journal of Cancer Research and Clinical Oncology.

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study

Yun-fei Yuan, Wenwu Liu, Chen-Wei Wang, 2020, Annals of translational medicine.

Comparison of the prognostic value of inflammation‐based scores in early recurrent hepatocellular carcinoma after hepatectomy

Yun-fei Yuan, Wenwu Liu, Ruhai Zou, 2020, Liver international : official journal of the International Association for the Study of the Liver.

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma

Yun-fei Yuan, Jiliang Qiu, Binkui Li, 2023, Cancer Cell International.

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma

Hong Zhang, Yun-fei Yuan, Wenwu Liu, 2021, Journal of experimental & clinical cancer research : CR.

Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation

Jingxian Shen, Yun-fei Yuan, Wenwu Liu, 2019, European Radiology.

The efficacy and safety of long- versus short-interval transarterial chemoembolization in unresectable hepatocellular carcinoma

Yun-fei Yuan, Wenwu Liu, Ruhai Zou, 2018, Journal of Cancer.

A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade.

Yun-fei Yuan, Chen-Wei Wang, Jiliang Qiu, 2022, American journal of cancer research.

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma

Yun-fei Yuan, Ruhai Zou, Chen-Wei Wang, 2021, Annals of surgery open : perspectives of surgical history, education, and clinical approaches.

S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression

Y. Niu, Yun-fei Yuan, Wenwu Liu, 2022, Advanced science.

Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy

Yun-fei Yuan, Wenwu Liu, Chen-Wei Wang, 2020, Digestive Surgery.

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis

Jingxian Shen, Yun-fei Yuan, Wenwu Liu, 2019, Therapeutic advances in medical oncology.

Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma

Yun-fei Yuan, Wenwu Liu, Chen-Wei Wang, 2020, Theranostics.

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma

Yun-fei Yuan, Wenwu Liu, Chen-Wei Wang, 2022, Journal of experimental & clinical cancer research : CR.

More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation

Wei-Dong Zhang, Yun-fei Yuan, Chen-Wei Wang, 2022, Journal of oncology.

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer

Y. Niu, Yun-fei Yuan, Guocan Wang, 2023, Nature Communications.

Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis.

Yun-fei Yuan, Jiliang Qiu, Wei He, 2023, American journal of surgery.

Comprehensive Analysis of m6A Modi�cation in Immune In�ltration, Metabolism and Drug Resistance in Hepatocellular Carcinoma

Chen-Wei Wang, Kai Li, Yunxing Shi, 2023 .

Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence

Ruhai Zou, Chen-Wei Wang, Jiliang Qiu, 2023, Journal of Cancer Research and Clinical Oncology.

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

W. Lau, Yun-fei Yuan, Jiliang Qiu, 2023, International journal of surgery.

NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3

Y. Niu, Yun-fei Yuan, Chen-Wei Wang, 2022, Cell Death & Disease.

Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma

Chen-Wei Wang, Jiliang Qiu, Zhiwen Yang, 2024, Cancer cell international.

Extremely High Preoperative Alpha-Fetoprotein Level is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients

Yun-fei Yuan, Wenwu Liu, Chen-Wei Wang, 2019, The American surgeon.

Regorafenib with immunotherapy versus regorafenib alone as second‐line treatment for hepatocellular carcinoma: A multicenter real‐world study

Jiliang Qiu, Wei He, Binkui Li, 2024, Cancer medicine.